S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
Top-Rated StocksTop-RatedMost-Upgraded StocksMost-Upgraded
NYSE:BSX

Boston Scientific (BSX) Stock Forecast, Price & News

$52.10
-0.73 (-1.38%)
(As of 05:37 PM ET)
Compare
Today's Range
$51.54
▼
$53.16
50-Day Range
$50.19
▼
$54.68
52-Week Range
$38.22
▼
$55.38
Volume
8.48 million shs
Average Volume
8.07 million shs
Market Capitalization
$76.29 billion
P/E Ratio
86.83
Dividend Yield
N/A
Price Target
$60.10
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Boston Scientific MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
15.3% Upside
$60.10 Price Target
Short Interest
Healthy
0.81% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.10
Upright™ Environmental Score
News Sentiment
0.50mentions of Boston Scientific in the last 14 days
Based on 48 Articles This Week
Insider Trading
Selling Shares
$11.57 M Sold Last Quarter
Proj. Earnings Growth
12.06%
From $1.99 to $2.23 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.91 out of 5 stars

Medical Sector

46th out of 976 stocks

Surgical & Medical Instruments Industry

9th out of 100 stocks

See Top Rated MarketRank™ Stocks Here

BSX stock logo

About Boston Scientific (NYSE:BSX) Stock

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX Price History

BSX Stock News Headlines

August 30, 2023 | marketbeat.com
A Significant Reversal is in Sight for These 5 Med Tech Companies (BSX)
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.
August 29, 2023 | marketbeat.com
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M (BSX)
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up
September 27, 2023 | Chaikin Analytics (Ad)
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
September 27, 2023 | benzinga.com
Here's How Much $100 Invested In Boston Scientific 15 Years Ago Would Be Worth Today
September 27, 2023 | finance.yahoo.com
Boston Scientific: Encouraging and Empowering Tomorrow’s STEM Pioneers
September 26, 2023 | finance.yahoo.com
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
September 26, 2023 | msn.com
From stage in Boston, boygenius announces new EP
September 26, 2023 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) Receives Consensus Recommendation of "Buy" from Brokerages
September 27, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
September 26, 2023 | americanbankingnews.com
Brokerages Set Boston Scientific Co. (NYSE:BSX) PT at $60.10
September 25, 2023 | finance.yahoo.com
The Zacks Analyst Blog Highlights Amazon.com, Boeing, Regeneron, Boston Scientific and Waste Management
September 25, 2023 | msn.com
Boston Scientific (BSX) Set to Acquire Relievant Medsystems
September 25, 2023 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) Expected to Post Q1 2025 Earnings of $0.65 Per Share
September 24, 2023 | americanbankingnews.com
Barclays Increases Boston Scientific (NYSE:BSX) Price Target to $60.00
September 24, 2023 | americanbankingnews.com
Boston Scientific Co. (NYSE:BSX) EVP Sells $872,685.00 in Stock
September 23, 2023 | msn.com
UBS Maintains Boston Scientific (BSX) Buy Recommendation
September 23, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) Price Target Increased to $64.00 by Analysts at BTIG Research
September 23, 2023 | americanbankingnews.com
Royal Bank of Canada Increases Boston Scientific (NYSE:BSX) Price Target to $61.00
September 23, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) Price Target Raised to $63.00
September 23, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) PT Raised to $60.00 at Mizuho
September 23, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) PT Raised to $60.00
September 23, 2023 | americanbankingnews.com
UBS Group Boosts Boston Scientific (NYSE:BSX) Price Target to $66.00
September 23, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) PT Raised to $64.00 at Canaccord Genuity Group
September 23, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) Receives Buy Rating from Citigroup
September 23, 2023 | americanbankingnews.com
Boston Scientific's (BSX) Buy Rating Reaffirmed at Truist Financial
September 22, 2023 | nasdaq.com
Baird Maintains Boston Scientific (BSX) Outperform Recommendation
September 22, 2023 | americanbankingnews.com
Needham & Company LLC Reiterates Buy Rating for Boston Scientific (NYSE:BSX)
See More Headlines
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Company Calendar

Last Earnings
7/27/2023
Today
9/27/2023
Next Earnings (Confirmed)
10/26/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:BSX
CUSIP
10113710
CIK
885725
Web
www.bostonscientific.com
Phone
(508) 683-4000
Fax
508-683-5675
Employees
45,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$60.10
High Stock Price Forecast
$66.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+16.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
17 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.60
Trailing P/E Ratio
86.32
Forward P/E Ratio
26.03
P/E Growth
2.11
Net Income
$698 million
Net Margins
6.81%
Pretax Margin
11.27%
Return on Equity
15.16%
Return on Assets
8.31%

Debt

Debt-to-Equity Ratio
0.46
Current Ratio
1.29
Quick Ratio
0.80

Sales & Book Value

Annual Sales
$12.68 billion
Price / Sales
5.98
Cash Flow
$2.50 per share
Price / Cash Flow
20.68
Book Value
$12.27 per share
Price / Book
4.22

Miscellaneous

Outstanding Shares
1,464,220,000
Free Float
1,456,463,000
Market Cap
$75.83 billion
Optionable
Optionable
Beta
0.78

Social Links

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Michael F. MahoneyMr. Michael F. Mahoney (Age 58)
    Chairman, Pres & CEO
    Comp: $3.77M
  • Mr. Daniel J. BrennanMr. Daniel J. Brennan (Age 57)
    Exec. VP & CFO
    Comp: $1.69M
  • Mr. Joseph M. FitzgeraldMr. Joseph M. Fitzgerald (Age 59)
    Exec. VP & Group Pres of Cardiology
    Comp: $1.53M
  • Mr. Jeffrey B. MirvissMr. Jeffrey B. Mirviss (Age 57)
    Exec. VP & Pres of Peripheral Interventions
    Comp: $1.15M
  • Mr. Arthur Crosswell Butcher (Age 52)
    Exec. VP and Group Pres of MedSurg & Asia Pacific
    Comp: $1.4M
  • Mr. John Bradley SorensonMr. John Bradley Sorenson (Age 55)
    Exec. VP of Global Operations
  • Mr. Jonathan R MonsonMr. Jonathan R Monson
    Sr. VP, Global Controller & Chief Accounting Officer
  • Ms. Jodi Euerle EddyMs. Jodi Euerle Eddy (Age 50)
    Sr. VP and Chief Information & Digital Officer
  • Ms. Susan Vissers Lisa (Age 54)
    VP of Investor Relations
  • Mr. Vance R. BrownMr. Vance R. Brown
    Sr. VP, Gen. Counsel & Corp. Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













BSX Stock - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 1 hold rating, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.

What is Boston Scientific's stock price forecast for 2023?

17 Wall Street research analysts have issued 1-year target prices for Boston Scientific's shares. Their BSX share price forecasts range from $50.00 to $66.00. On average, they predict the company's share price to reach $60.10 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.

How have BSX shares performed in 2023?

Boston Scientific's stock was trading at $46.27 at the beginning of the year. Since then, BSX shares have increased by 11.9% and is now trading at $51.79.
View the best growth stocks for 2023 here.

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 12,220,000 shares, an increase of 40.1% from the August 15th total of 8,720,000 shares. Based on an average daily volume of 7,090,000 shares, the short-interest ratio is presently 1.7 days.
View Boston Scientific's Short Interest.

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our BSX earnings forecast.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) issued its earnings results on Thursday, July, 27th. The medical equipment provider reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.49 by $0.04. The medical equipment provider had revenue of $3.60 billion for the quarter, compared to analysts' expectations of $3.50 billion. Boston Scientific had a net margin of 6.81% and a trailing twelve-month return on equity of 15.16%. The company's quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.44 EPS.
Read the conference call transcript.

What ETFs hold Boston Scientific's stock?

ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include Simplify Health Care ETF (PINK), Goldman Sachs Future Health Care Equity ETF (GDOC), Fidelity Disruptive Medicine ETF (FMED), iShares U.S. Medical Devices ETF (IHI), Global X Aging Population ETF (AGNG), BlackRock Future Health ETF (BMED), BNY Mellon Sustainable US Equity ETF (BKUS) and JPMorgan Social Advancement ETF (UPWD).

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific issued an update on its FY 2023 earnings guidance on Thursday, September, 21st. The company provided earnings per share (EPS) guidance of $1.96-$2.00 for the period, compared to the consensus EPS estimate of $1.99. The company issued revenue guidance of $14.00 billion-$14.00 billion, compared to the consensus revenue estimate of $14.09 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by many different institutional and retail investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (19.35%), State Street Corp (4.32%), Geode Capital Management LLC (1.78%), Bollard Group LLC (1.62%), Artisan Partners Limited Partnership (1.30%) and Bank of New York Mellon Corp (1.23%). Insiders that own company stock include Arthur C Butcher, Charles J Dockendorff, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Vance R Brown, Wendy Carruthers and William F Bruss.
View institutional ownership trends.

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $51.79.

How much money does Boston Scientific make?

Boston Scientific (NYSE:BSX) has a market capitalization of $75.83 billion and generates $12.68 billion in revenue each year. The medical equipment provider earns $698 million in net income (profit) each year or $0.60 on an earnings per share basis.

How many employees does Boston Scientific have?

The company employs 45,000 workers across the globe.

Does Boston Scientific have any subsidiaries?
The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The official website for the company is www.bostonscientific.com. The medical equipment provider can be reached via phone at (508) 683-4000, via email at bsxinvestorrelations@bsci.com, or via fax at 508-683-5675.

This page (NYSE:BSX) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -